Circle Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$794K Sell
5,196
-134
-3% -$20.5K 0.01% 164
2025
Q4
$735K Sell
5,330
-90
-2% -$11.8K 0.01% 159
2025
Q3
$695K Buy
5,420
+554
+11% +$67.6K 0.01% 149
2025
Q2
$589K Sell
4,866
-253
-5% -$28.5K 0.01% 158
2025
Q1
$571K Hold
5,119
0.01% 156
2024
Q4
$498K Buy
5,119
+294
+6% +$31.4K 0.01% 174
2024
Q3
$555K Sell
4,825
-405
-8% -$46K 0.01% 163
2024
Q2
$557K Hold
5,230
0.01% 153
2024
Q1
$506K Buy
5,230
+337
+7% +$34.6K 0.01% 145
2023
Q4
$494K Sell
4,893
-63
-1% -$6.08K 0.01% 137
2023
Q3
$505K Buy
4,956
+575
+13% +$58.4K 0.01% 131
2023
Q2
$442K Hold
4,381
0.06% 110
2023
Q1
$403K Hold
4,381
0.06% 118
2022
Q4
$397K Hold
4,381
0.06% 115
2022
Q3
$333K Hold
4,381
0.05% 127
2022
Q2
$370K Hold
4,381
0.06% 123
2022
Q1
$384K Buy
4,381
+550
+14% +$47.6K 0.05% 141
2021
Q4
$335K Hold
3,831
0.04% 154
2021
Q3
$313K Hold
3,831
0.05% 148
2021
Q2
$350K Buy
3,831
+640
+20% +$57K 0.05% 149
2021
Q1
$273K Sell
3,191
-215
-6% -$19.3K 0.04% 148
2020
Q4
$322K Buy
3,406
+818
+32% +$71.5K 0.05% 183
2020
Q3
$225K Buy
+2,588
New +$224K 0.04% 193

Other funds holding NVS

Circle Wealth Management's NVS Position: Q1 2026 in Review

Circle Wealth Management reduced its Novartis (NVS) stake by 2.5% in Q1 2026, selling an estimated $20.5K and leaving 5,196 shares worth $794K. The position accounts for 0.01% of the portfolio, ranked #164.

Circle Wealth Management first reported a position in NVS in Q3 2020 and has held it in 23 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Circle Wealth Management held 5,196 shares of Novartis worth $794K as of Q1 2026.
  • Circle Wealth Management sold 134 Novartis shares in Q1 2026, an estimated $20.5K.
  • Novartis made up 0.01% of Circle Wealth Management's portfolio in Q1 2026, its #164 holding.
  • Circle Wealth Management first reported a position in Novartis in Q3 2020 and has held it in 23 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Circle Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.